title: Assessment of depression among African American light smokers.
abstract: Given the relationship between depression and smoking, we compared the two-item Patient Health Questionnaire (PHQ-2) and 10-item Center for Epidemiological Studies Depression Scale (CESD-10) in assessing depressive symptoms among African American light smokers in a clinical trial of bupropion. Of 539 participants, 21.3 percent reported significant depressive symptoms on the PHQ-2, 31.0 percent screened positive per CESD-10, 36.8 percent reported symptoms on either, and 15.6 percent screened positive on both (r = 0.47, p < .001). Having depressive symptoms was associated with less education, decreased positive affect and social support, and greater levels of negative affect and perceived stress. Cessation treatment should assess depression and address these symptoms.
authors.affiliation: Emory University School of Public Health, Atlanta, GA 30322, USA. cjberg@emory.edu
authors.forename: Carla J
authors.initials: CJ
authors.lastname: Berg
authors.forename: Lisa Sanderson
authors.initials: LS
authors.lastname: Cox
authors.forename: Won S
authors.initials: WS
authors.lastname: Choi
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Mayo
authors.forename: Ron
authors.initials: R
authors.lastname: Krebill
authors.forename: Carrie A
authors.initials: CA
authors.lastname: Bronars
authors.forename: Jasjit S
authors.initials: JS
authors.lastname: Ahluwalia
mesh_terms: D000328:Adult; D001741:Black or African American / Q000523:psychology*; D003863:Depression / Q000208:ethnology / Q000523:psychology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012907:Smoking / Q000453:epidemiology*; D011795:Surveys and Questionnaires; D014029:Tobacco Use Disorder